Patients may talk about Ozempic face, characterized by the loss of facial fat
THC, cocaine, opioids, amphetamines, PCP, with expanded panels adding benzodiazepines, barbiturates, and others
The Science Triple-Agonist Technology Retatrutide simultaneously activates three metabolic receptor pathways: GLP-1, GIP, and glucagon
Monitor for nausea, appetite changes, and injection site reactions
These categories are organized by physiological domain and translational barrier rather than by peptide family or receptor class, reflecting the cross-cutting nature of underexploration
Pills are also easier to manufacture than injectable pens, which could help avoid the frustrating supply problems that slowed earlier GLP-1 launches